L‐type calcium channels and psychiatric disorders: A brief review
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Emerging evidence from genome‐wide association studies (GWAS) support the association of polymorphisms in the alpha 1C subunit of the L‐type voltage‐gated calcium channel gene (CACNA1C) with bipolar disorder. These studies extend a rich prior literature implicating dysfunction of L‐type calcium channels (LTCCs) in the pathophysiology of neuropsychiatric disorders. Moreover, calcium channel blockers reduce Ca 2+flux by binding to the α1 subunit of the LTCC and are used extensively for treating hypertension, preventing angina, cardiac arrhythmias and stroke. Calcium channel blockers have also been studied clinically in psychiatric conditions such as mood disorders and substance abuse/dependence, yielding conflicting results. In this review, we begin with a summary of LTCC pharmacology. For each category of disorder, this article then provides a review of animal and human data. In particular, we extensively focus on animal models of depression and clinical trials in mood disorders and substance abuse/dependence. Through examining rationale and study design of published clinical trials, we provide some of the possible reasons why we still do not have definitive evidence of efficacy of calcium‐channel antagonists for mood disorders. Refinement of genetic results and target phenotypes, enrollment of adequate sample sizes in clinical trials and progress in physiologic and pharmacologic studies to synthesize tissue and isoform specific calcium channel antagonists, are all future challenges of research in this promising field. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure and Regulation of Voltage-Gated Ca 2+ Channels
Catterall, W. A. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.521 · Cited by 2,344
CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism
Splawski, I., Timothy, K. W., Sharpe, L. M., Decher, N., Kumar, P., Bloise, R., Napolitano, C., Schwartz, P. J., Joseph, R. M., Condouris, K., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.011 · Cited by 1,586 · cited 1×
“2 channels provoke phenotypes including cognitive impairment, mental retardation, and autistic features such as in Timothy syndrome, a devastating disorder also characterized by severemultiorgan abnormalities and global cognitive impairment [Splawski et al., 2004, 2005].”
BackgroundWellcome Trust Case Control Consortium, Ferreira, M. A. R., O'Donovan, M. C., Meng, Y. A., Jones, I. R., Ruderfer, D. M., Jones, L., Fan, J., Kirov, G., Perlis, R. H., et al. (2008) · Nature Genetics · doi:10.1038/ng.209 · Cited by 1,237 · cited 1×
“3, with bipolar disorder [Ferreira et al., 2008; Sklar et al., 2008].”
BackgroundSelf-citationInositol Trisphosphate Receptor Ca2+Release Channels
Foskett, J. K., White, C., Cheung, K.-H., & Mak, D.-O. D. (2007) · Physiological Reviews · doi:10.1152/physrev.00035.2006 · Cited by 1,188 · cited 3×
“In fact, lithium has been shown to indirectly inhibit the inositol-1,4,5triphosphate receptor (InsP3R) functioning [Schlecker et al., 2006] that plays a fundamental role in calcium release from intracellular stores [Foskett et al., 2007].”
BackgroundRegulation of Gene Expression in Hippocampal Neurons by Distinct Calcium Signaling Pathways
Bading, H., Ginty, D. D., & Greenberg, M. E. (1993) · Science · doi:10.1126/science.8097060 · Cited by 1,157 · cited 1×
“3 are especially important for the communication between synapse and nucleus [Bading et al., 1993].”
BackgroundTsuno, N., Besset, A., & Ritchie, K. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1008 · Cited by 1,084
Forette, F. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.18.2046 · Cited by 898 · cited 1×
“Also, in clinical cohorts, subjects treated with lithium were shown to be at lower risk for Alzheimer’s disease and dementia [Forette et al., 2002; Nunes et al., 2007; Kessing et al., 2008].”
BackgroundComorbidity of migraine and depression: Investigating potential etiology and prognosis
Breslau, N., Lipton, R. B., Stewart, W. F., Schultz, L. R., & Welch, K. M. A. (2003) · Neurology · doi:10.1212/01.wnl.0000058907.41080.54 · Cited by 640
Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations
Splawski, I., Timothy, K. W., Decher, N., Kumar, P., Sachse, F. B., Beggs, A. H., Sanguinetti, M. C., & Keating, M. T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502506102 · Cited by 624
Wellcome Trust Case Control Consortium, Green, E. K., Grozeva, D., Jones, I., Jones, L., Kirov, G., Caesar, S., Gordon-Smith, K., Fraser, C., Forty, L., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.49 · Cited by 526 · cited 2×
“More recently, aUK research group [Green et al., 2009] showed that a risk allele in the CACNA1C was significantly more common in recurrent unipolar depression (n1⁄4 1,196) and schizophrenia (n1⁄4 479) patients than in controls (n1⁄4 15,316).”
BackgroundCommunication Between the Synapse and the Nucleus in Neuronal Development, Plasticity, and Disease
Cohen, S., & Greenberg, M. E. (2008) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.24.110707.175235 · Cited by 400
Psychiatric comorbidity of migraine
Hamelsky, S. W., & Lipton, R. B. (2006) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00576.x · Cited by 314
CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking
Anderson, S. M., Famous, K. R., Sadri-Vakili, G., Kumaresan, V., Schmidt, H. D., Bass, C. E., Terwilliger, E. F., Cha, J.-H. J., & Pierce, R. C. (2008) · Nature Neuroscience · doi:10.1038/nn2054 · Cited by 295
Lithium Treatment and Risk of Dementia
Kessing, L. V., Søndergård, L., Forman, J. L., & Andersen, P. K. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.11.1331 · Cited by 267 · cited 1×
“Also, in clinical cohorts, subjects treated with lithium were shown to be at lower risk for Alzheimer’s disease and dementia [Forette et al., 2002; Nunes et al., 2007; Kessing et al., 2008].”
BackgroundCACNA1H mutations in autism spectrum disorders
Splawski, I., Yoo, D. S., Stotz, S. C., Cherry, A., Clapham, D. E., & Keating, M. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603316200 · Cited by 255 · cited 1×
“Calcium channels have also been implicated in other neuropsychiatric diseases such as monogenic seizure, ataxia, migraine syndromes, and autism spectrum disorders [Gargus, 2006; Splawski et al., 2006] (see next section).”
BackgroundInherited Neuronal Ion Channelopathies: New Windows on Complex Neurological Diseases
Catterall, W. A., Dib-Hajj, S., Meisler, M. H., & Pietrobon, D. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3901-08.2008 · Cited by 237
Cain, C. K., Blouin, A. M., & Barad, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09113.2002 · Cited by 130 · cited 1×
“LTCC activity also appears to play an essential role in mouse models of fear memory, interacting with NMDA receptors [Bauer et al., 2002; Cain et al., 2002].”
BackgroundVerapamil for the Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Trial
Janicak, P. G., Sharma, R. P., Pandey, G., & Davis, J. M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.7.972 · Cited by 69
Verapamil treatment for women with bipolar disorder
Wisner, K. L., Peindl, K. S., Perel, J. M., Hanusa, B. H., Piontek, C. M., & Baab, S. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01338-5 · Cited by 41 · cited 6×
“Only two studies included subjects with bipolar depression and both examined the efficacy of verapamil [Hoschl andKozeny, 1989; Wisner et al., 2002].”
BackgroundInfluentialJohnson, B. A., Roache, J. D., Ait-Daoud, N., Wallace, C., Wells, L. T., & Wang, Y. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1998-0 · Cited by 33 · cited 2×
“…been reported in preliminary clinical studies examining stimulants’ abuse liability in humans [Muntaner et al., 1991; Rosse et al., 1994; Fabian and Silverstone, 1997; Johnson et al., 1999, 2004, 2005b; Malcolm et al., 1999; Gottschalk and Kosten, 2002; Sofuoglu et al., 2003; Roache et al., 2005].”
Result
Cited by
Craddock, N., & Sklar, P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60855-7 · Cited by 635
Genetic Risk for Schizophrenia: Convergence on Synaptic Pathways Involved in Plasticity
Hall, J., Trent, S., Thomas, K. L., O’Donovan, M. C., & Owen, M. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.011 · Cited by 290
CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease
Bhat, S., Dao, D. T., Terrillion, C. E., Arad, M., Smith, R. J., Soldatov, N. M., & Gould, T. D. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.001 · Cited by 271
Identification of Pathways for Bipolar Disorder: A Meta-analysis
Nurnberger, J. I., Koller, D. L., Jung, J., Edenberg, H. J., Foroud, T., Guella, I., Vawter, M. P., & Kelsoe, J. R. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.176 · Cited by 234
MiR-137: an important player in neural development and neoplastic transformation
Mahmoudi, E., & Cairns, M. J. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.150 · Cited by 198
Metadata
- Authors
- Casamassima, F., Hay, A. C., Benedetti, A., Lattanzi, L., Cassano, G. B., & Perlis, R. H.
- Venue
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Publisher
- Wiley
- Published
- 2010-09-30
- Volume
- 153B
- Issue
- 8
- Pages
- 1373-1390
- ISSN
- 1552-4841 (ISSN-L)
- 1552-485X
- OpenAlex
- W1989524155
- Cited by
- 135
- References
- 20
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.